Pfizer is looking to sell its remaining stake in Covid-19 vaccine partner BioNTech. Have the good days finally come to an end ...

SC lawmakers advanced a bill that would require a disclaimer for COVID-19 vaccinations. Physicians have broadly encouraged ...

AGC Biologics today announced it is partnering with Repair Biotechnologies to tackle one of the world's most persistent health challenges and cause of mortality. The collaboration will focus on ...

Strategic Hire Strengthens Late Phase and Commercial Readiness as Elicio Advances Lymph Node-Targeted Immunotherapy ...

A significant development emerged on November 13 when Pfizer announced it had sold 54.7% of its stake in BioNTech, retaining only $163.5 million worth of shares. This move marks a substantial shift in ...

Jefferies London Healthcare Conference 2025 November 19, 2025 4:00 AM ESTCompany ParticipantsDavid Denton - Executive VP ...

BioNTech formally launched its public takeover bid on October 22, 2025, offering CureVac shareholders approximately $5.46 per share in BioNTech American Depositary Shares. The exchange ratio includes ...

Today in History for Nov. 19: In 1794, the United States and Britain signed the "Jay Treaty" concerning trade boundaries and commerce.

(Nov 19): Hyundai Motor Co chief executive officer José Muñoz said the South Korean automaker received an apology from the US ...

Many of the new CDC panel members share a connection to a little-known think tank making its mark in President Donald Trump’s Washington: the Brownstone Institute.

His institute’s covid contrarians seek to limit the government’s role in protecting Americans from disease. The Austin, Texas ...

WARMINSTER, PA — Arbutus Biopharma Corporation (Nasdaq: ABUS) reported third quarter 2025 financial results and released new ...